Author:
Itoh Kuniaki,Sasaki Yasutsuna,Miyata Yoshifumi,Fujii Hirofumi,Ohtsu Tomoko,Wakita Hisashi,Igarashi Tadahiko,Abe Kaoru
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference10 articles.
1. Collins JM, Zaharko DS, Dedrick RL, Chabner BA (1986) Potential roles for preclinical pharmacology in phase I clinical trials. Cancer Treat Rep 70: 73?80
2. Decoster G, Stein G, Holdener EE (1990) Responses and toxic deaths in phase I clinical trials. Ann Oncol 1: 175?181
3. Estey E, Hoth D, Simon R, Marsoni S, Leyland-Jones B, Wittes R (1986) Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep 70: 1105?1115
4. Negoro S, Fukuoka M, Masuda N, Takada M, Kusunoki S, Matsui K, Takifuji N, Kudoh S, Niitani H, Taguchi T (1991) Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer. J Natl Cancer Inst 83: 1164
5. Penta JS, Rosner GL, Trump DL (1992) Choice of starting dose and escalation for phase I studies of antitumor agents. Cancer Chemother Pharmacol 31: 247?250
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献